Automate Your Wheel Strategy on TDOC
With Tiblio's Option Bot, you can configure your own wheel strategy including TDOC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TDOC
- Rev/Share 14.4515
- Book/Share 8.0841
- PB 0.8894
- Debt/Equity 0.7209
- CurrentRatio 2.6714
- ROIC -0.0958
- MktCap 1270408290.0
- FreeCF/Share 1.3566
- PFCF 5.3235
- PE -6.0998
- Debt/Assets 0.3543
- DivYield 0
- ROE -0.1418
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | TDOC | Mizuho | -- | Neutral | -- | $10 | July 25, 2025 |
| Reiterated | TDOC | Jefferies | -- | Hold | $8 | $10 | Sept. 17, 2024 |
News
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Negative
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Read More
Teladoc Health: Still Struggling To Find A Catalyst
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Teladoc Health remains a deep value play at $7, trading at just 5-6x EBITDA, but lacks a clear growth catalyst. Revenue and user metrics are declining across core segments, with BetterHelp and Chronic Care both losing momentum and failing to innovate. Recent acquisitions (UpLift, Catapult Health) have not meaningfully expanded Teladoc's platform or addressed its reliance on basic telehealth connections.
Read More
Teladoc Health Earnings: Not Dead Yet
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Teladoc's Q2 2025 earnings reaffirm strong free cash flow guidance, with the potential to reach $220 million in the next twelve months. Despite an attractive 7x next year's free cash flow valuation, revenue growth remains stagnant and threatens the bull case. Profitability and an improving balance sheet keep me tepidly bullish, but lack of growth and competitive pressures are major risks.
Read More
Teladoc Health, Inc. (TDOC) Q2 2025 Earnings Call Transcript
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Neutral
Teladoc Health, Inc. Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Michael Minchak - Vice President of Investor Relations Conference Call Participants Sarah Elizabeth James - Cantor Fitzgerald & Co., Research Division Charles Rhyee - TD Cowen, Research Division Daniel R. Grosslight - Citigroup Inc., Research Division David Harrison Roman - Goldman Sachs Group, Inc., Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Jailendra P.
Read More
Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.28 per share a year ago.
Read More
HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Hims & Hers and Teladoc Health are reshaping virtual care, but which has the edge in earnings growth and strategic expansion? Let's see.
Read More
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Negative
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Teladoc Health to Announce Second Quarter 2025 Financial Results
Published: July 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day.
Read More
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Read More
Teladoc Health, Inc. (TDOC) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
Published: June 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Teladoc Health, Inc. (NYSE:TDOC ) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 11:30 AM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division David Harrison Roman Very pleased to welcome the management team from Teladoc, Chuck Divita, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. Very much appreciate you taking the time to participate in the conference and look forward to getting an update on Teladoc here.
Read More
Teladoc Health to Participate in Upcoming Investor Conference
Published: June 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations.
Read More
Which Telehealth Stock Should You Be Targeting?
Published: June 03, 2025 by: Schaeffers Research
Sentiment: Positive
Hims & Hers Health Inc (NYSE:HIMS) stock made waves in premarket trading, after the telehealth firebrand announced the pending acquisition of ZAVA, a European digital health platform.
Read More
Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report?
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Negative
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Read More
Teladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure
Published: May 16, 2025 by: Benzinga
Sentiment: Negative
JPMorgan analyst Lisa C. Gill maintained a Neutral rating on Teladoc Health, Inc TDOC on Thursday with a price target of $9, down from the prior $11.
Read More
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
Teladoc Health expects Integrated Care members to be between 101 million and 103 million in 2025.
Read More
Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Teladoc Health, Inc. (NYSE:TDOC ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Corporate Participants Mike Minchak - Head of Investor Relations Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Jessica Tassan - Piper Sandler David Roman - Goldman Sachs Daniel Grosslight - Citi Eduardo Ron - Truist Elizabeth Anderson - Evercore Charles Rhyee - Cowen Operator Good afternoon, thank you for attending today's Teladoc Health First Quarter 2025 Earnings Call. My name is Cole and I'll be the moderator for today's call.
Read More
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their platforms. Which one is a better investment?
Read More
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade)
Published: April 16, 2025 by: Seeking Alpha
Sentiment: Negative
Teladoc Health, Inc.'s stock has declined significantly, from a high of $14 per share in February to $7 per share, with ongoing financial struggles and underperformance in key segments. The company reported a net loss of $1 billion in 2024, with declining revenues in its BetterHelp segment and minimal growth in Integrated Care. Despite efforts to cut costs and new initiatives like the Catapult Health acquisition and a partnership with Eli Lilly, Teladoc's value proposition remains unclear.
Read More
Teladoc (TDOC) Flat As Market Sinks: What You Should Know
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Negative
Teladoc (TDOC) reachead $8.64 at the closing of the latest trading day, reflecting no change compared to its last close.
Read More
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
Published: March 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the latest trading session, Teladoc (TDOC) closed at $8.49, marking a +1.19% move from the previous day.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Published: March 17, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Published: March 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner
Published: March 13, 2025 by: PRNewsWire
Sentiment: Neutral
The partnership enables Teladoc Health's employer clients and members more streamlined and fully integrated access to Carrum's value-based Centers of Excellence network for specialty care SAN FRANCISCO , March 13, 2025 /PRNewswire/ -- Carrum Health, the leader in value-based Centers of Excellence (COE) for specialty care, today announced a strategic partnership with Teladoc Health (NYSE: TDOC), the global leader in virtual care. The new arrangement will allow Teladoc Health's providers to seamlessly refer eligible members needing specialty care into Carrum's nationwide network of rigorously vetted, high quality providers.
Read More
Cylinder joins Teladoc Health's Connected Care Program to expand access to virtual digestive care
Published: March 12, 2025 by: GlobeNewsWire
Sentiment: Neutral
CHICAGO, March 12, 2025 (GLOBE NEWSWIRE) -- Cylinder , the leading virtual digestive health provider, today announced its partnership with Teladoc Health (NYSE: TDOC), the global leader in virtual care, to expand access to high-quality, personalized gastrointestinal care. Through this collaboration, Teladoc Health's health plan and employer customers can easily provide members access to Cylinder's evidence-based digestive health platform, through streamlined administrative services and integration enablement.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Published: March 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss
Published: March 06, 2025 by: Benzinga
Sentiment: Positive
Telemedicine operator Teladoc Health Inc TDOC has entered a pharmacy integration agreement with Eli Lilly And Co's LLY LillyDirect, a direct-to-consumer pharmacy partner, to streamline access to Zepbound (tirzepatide) for members of Teladoc's Comprehensive Weight Care Program.
Read More
Teladoc Health Enhances Prism Platform for Better Virtual Care
Published: March 05, 2025 by: Zacks Investment Research
Sentiment: Positive
TDOC upgrades its Prism platform with AI-powered tools, improved referrals and data integration, enhancing care coordination to bolster its member base.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Published: March 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
About Teladoc Health, Inc. (TDOC)
- IPO Date 2015-06-30
- Website https://www.teladochealth.com
- Industry Medical - Healthcare Information Services
- CEO Charles Divita III, CPA
- Employees 4620